Part of our AI Trading ecosystem
AI Trading Tool
The main AI trading tool page
AI Stock Analysis
4,600+ stocks analyzed
AI Stock Picks
Daily AI-generated picks
AI Stock Picker
Scan the universe for ideas
Stock Recommendations
Ranked AI research ideas
AI Trading Signals
Real-time momentum alerts
AI Stock Screener
Scan 4,600+ stocks live
Best AI Trading Tools
#1 pick: Stockinhood
How AI Trading Works
The technology explained
AI Stock Predictions
Multi-timeframe targets
$0.43
Current Price
13.66M
Market Cap
-2.6
P/E Ratio
$50
52W High
$0.36
52W Low
CEO
Michael Shleifer
Employees
2
Year Founded
2020
Headquarters
New York, NY
Sector / Industry
Healthcare · Biotechnology
Market Cap
13.66M
Today's High
$0.65
Today's Low
$0.40
Open
$0.48
Previous Close
$0.42
52-Week High
$50.00
52-Week Low
$0.36
Today's Volume
5.88M
Avg. Volume
1.89M
Overnight Volume
1.32K
Shares Outstanding
32.5M
P/E Ratio
-2.60
EPS
$-0.16
Beta
1.45
Dividend Yield
0.00%
Live market stats are a premium feature
These stats are from a cached snapshot. Unlock real-time data with lifetime access — $19.99.
Quarterly expected vs. actual performance
| Quarter | Date | EPS Est. | EPS Actual | Surprise | Rev. Est. | Rev. Actual |
|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-15 | -0.05 | -0.07 | -40% | $0.2M | $0.15M |
| Q1 2026 | 2026-05-15 | -0.02 | -0.02 | +0% | $0.0B | $0.0B |
| Q4 2025 | 2026-03-10 | -0.02 | -0.02 | +0% | $0.0B | $0.0B |
| Q3 2025 | 2025-11-14 | -0.02 | -0.02 | +0% | $0.0B | $0.0B |
Earnings data is AI-compiled from public sources and may be delayed or approximate. Not financial advice.
Price History
Instinct Bio Technical (BIOT) recently completed its business combination with Relativity Acquisition Corp, making its Nasdaq debut on July 24, 2026 [10, 18]. The company is currently transitioning from a blank-check entity to an operating business focused on regenerative medicine and aesthetics, notably launching the 'GENRÊVER CLINIC' brand in Indonesia to establish a recurring-revenue platform [10, 18]. While the stock has experienced a massive decline of over 95% from its initial SPAC-related highs of $50.00, technical indicators as of late August 2026 show a bullish moving average trend as the price stabilizes near its 52-week low [7, 13]. The extremely small market capitalization of $13.66M and a P/E ratio of -2.60 reflect the high-risk, early-stage nature of the venture [13]. Investors should monitor the execution of the Indonesian clinic rollout as a primary catalyst for medium-term price recovery.
7-Day Target
$0.45
30-Day Target
$0.65
6-Month Target
$50.00
AI Confidence
Risk Level
High
Analyst Target
$2.5
Biotricity's recurring revenue model, driven by its flagship BioFlux and Bioheart platforms, positions it to scale significantly as remote monitoring becomes the standard of care in cardiology. The integration of proprietary AI analytics offers a defensible competitive moat and high gross margins as adoption grows among healthcare providers.
The company faces intense competition from established medical device manufacturers and risks significant cash burn while attempting to achieve widespread clinical adoption. Persistent delays in insurance reimbursement cycles and limited capital market access could severely impact operational sustainability.
Biotricity Inc. is a medical diagnostic technology company specializing in innovative, AI-driven remote patient monitoring solutions for cardiovascular and chronic disease management. The company focuses on bridging the gap between clinical-grade diagnostics and consumer wearable technology to improve patient outcomes.
Unlock unlimited AI stock analysis, market signals, and daily briefings for a one-time payment of $19.99.
30-day money-back guarantee • Secure payment by Square
Stockinhood's AI generates multi-timeframe price targets for BIOT (Instinct Bio Technical Company Holdings Inc.), including 7-day, 30-day, and 6-month outlooks based on market data, technical indicators, and news sentiment. These estimates are for informational purposes only and do not constitute financial advice.
Our AI assigns a sentiment signal (Bullish, Bearish, or Neutral) to BIOT based on multiple factors including price trends, momentum, and market conditions. The current AI signal is Bullish. This is AI-generated research, not financial advice — always consult a licensed advisor before investing.
The AI-generated price target for BIOT is based on multi-timeframe analysis and represents a hypothetical scenario, not a guarantee. The current price is $0.43. Price targets are educational estimates and should not be relied upon for investment decisions.
Continued reliance on external financing to fund operations and R&D Dependency on fluctuating Medicare and private insurance reimbursement rates Intense competition from larger, better-capitalized incumbents in the digital health space Challenges in scaling clinical sales and distribution networks All risk analysis is informational only and not financial advice.
Instinct Bio Technical Company Holdings Inc. (BIOT) operates in the Healthcare sector, specifically the Biotechnology industry. This classification helps investors understand the company's business focus and compare it with peers in the same sector.
AI Stock Analysis
AI research on 4,600+ stocks
Best AI Trading Tools
15 AI trading tools tested & compared
Stock Analysis
Browse 7,700+ AI stock predictions
Financial Blog
AI-generated market insights daily
Financial Glossary
40+ stock market terms defined
Free Calculators
Position size, dividend yield & risk-reward tools
Original Research
Citable AI stock-market data studies
Social Buzz
Real-time social sentiment tracking